Lifestyle intervention can be effective when treating non-alcoholic fatty liver diseases
(NAFLD) patients. Weight loss decreases cardiovascular and diabetes risk and can also …

Nonalcoholic fatty liver disease (NAFLD) is emerging as a major public health problem
because of its association with increased cardiovascular and liver-related morbidity and …

Aim The diagnosis of non‐alcoholic steatohepatitis (NASH) is based on the individual
histological features: steatosis, lobular inflammation and ballooning. Non‐alcoholic fatty liver …

A few studies found polycyclic aromatic hydrocarbons (PAHs) were associated with serum
uric acid (SUA) or hyperuricemia (HUA). However, the longitudinal study is vacant, and the …

Background The association between hyperuricaemia and nonalcoholic fatty liver disease
(NAFLD), one of the leading causes of cirrhosis worldwide, has been demonstrated in recent …

Background It is unclear the role of longitudinal trajectory of serum uric acid (SUA) on the
development of non-alcoholic fatty liver disease (NAFLD). We aimed to determine whether …

Background Hyperuricemia is a recognised risk factor for the development of nonalcoholic
fatty liver disease (NAFLD). This study aims to investigate the therapeutic effect of resveratrol …

Background The diagnosis and comprehension of nonalcoholic fatty liver disease (NAFLD),
recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD) are …

Background Epidemiological evidence suggests sex difference in serum uric acid (SUA) and
alanine aminotransferase (ALT) might be a potential explanation for the gender difference in …

To examine the association between uric acid levels and liver enzyme functions amongst
adults with hyperuricemia and gout in the United States. The National Health and Nutrition …